Provided by Tiger Fintech (Singapore) Pte. Ltd.

Proteostasis Therapeutics

1.11
0.0000
Volume:- -
Turnover:- -
Market Cap:2.90M
PE:-0.07
High:1.11
Open:1.11
Low:1.11
Close:1.11
Loading ...
Jun 07, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 07, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
Apr 22, 2021

Major Issues Report

8-K - Current report
Apr 08, 2021

Major Issues Report

8-K/A [Amend] - Current report
Apr 08, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 03, 2021

Major Issues Report

8-K/A [Amend] - Current report
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals